Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Despite its therapeutic promise, more studies are needed to confirm its efficacy and safety for clinical use
29 (4 Pt 2): 51721
Estn indicados para: Diabetes tipo 2 (DM2) : Mejora el control glucmico y permite una reduccin de eventos cardiovasculares en pacientes con DM2 y enfermedad cardiovascular establecida (1)
Reported Side Effects Injection-site irritation (redness, mild swelling) usually resolves within minutes to hours
Semaglutide and similar GLP-1 medications work by slowing stomach emptying and reducing appetite signals in the brain, but they can also affect cardiovascular function
Most patients find that gastrointestinal side effects diminish substantially after the first 4-8 weeks, making persistence through this initial period worthwhile for many individuals who achieve significant glycaemic and weight benefits
